Leflunomide approved for rheumatoid arthritis; other drugs nearing approval.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D000077339:Leflunomide
D000276:Adjuvants, Immunologic; D007555:Isoxazoles; D000077339:Leflunomide